ResAppDx-EU v2.0 as an aid to Diagnose Respiratory Disease in Children

• Research type

  Research Study

• Full title

  A Pilot Study Evaluating the Use of ResAppDx-EU v2.0 as an aid to Diagnose Respiratory Disease in Children in an Emergency Department

• IRAS ID

  276243

• Contact name

  Sylvester Gomes

• Contact email

  Sylvester.Gomes@gstt.nhs.uk

• Sponsor organisation

  ResApp Health

• Duration of Study in the UK

  0 years, 4 months, 3 days

• Research summary

  This is an observational study comparing the diagnosis of respiratory illnesses using cough sound analytic algorithms from the ResAppDx-EU v2.0 to a clinical diagnosis (non-standard reference test), in paediatric patients.

  The purpose of this study is two-fold: (1) To compare diagnosis of childhood respiratory illnesses using the ResAppDx-EU v2.0 ID software to a clinical diagnosis determined by a clinical adjudication committee in a blinded setting in the UK; and (2) To establish a baseline for the costs and time scales of the current clinical care pathways for respiratory disease diagnosis in an emergency department.

• REC name

  London - Bromley Research Ethics Committee

• REC reference

  20/LO/0143

• Date of REC Opinion

  6 Apr 2020

• REC opinion

  Further Information Favourable Opinion